The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Reversible Conversion of Monomeric Human Prion Protein Between Native and Fibrilogenic Conformations
Abstract
Prion propagation involves the conversion of cellular prion protein (PrP C ) into a disease-specific isomer, PrP Sc , shifting from a predominantly α-helical to β-sheet structure. Here, conditions were established in which recombinant human PrP could switch between the native α conformation, characteristic of PrP C , and a compact, highly soluble, monomeric form rich in β structure. The soluble β form (β-PrP) exhibited partial resistance to proteinase K digestion, characteristic of PrP Sc , and was a direct precursor of fibrillar structures closely similar to those isolated from diseased brains. The conversion of PrP C to β-PrP in suitable cellular compartments, and its subsequent stabilization by intermolecular association, provide a molecular mechanism for prion propagation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,277
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
NMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257
Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, A. L. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00002-9 · Cited by 1,157
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease
Collinge, J., Palmer, M. S., & Dryden, A. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93128-v · Cited by 556
Self-citationJames, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10086 · Cited by 452
Eliezer, D., Yao, J., Dyson, H. J., & Wright, P. E. (1998) · Nature Structural Biology · doi:10.1038/nsb0298-148 · Cited by 371
Shyng, S. L., Huber, M. T., & Harris, D. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82340-7 · Cited by 315
Synthesis and trafficking of prion proteins in cultured cells.
Taraboulos, A., Raeber, A. J., Borchelt, D. R., Serban, D., & Prusiner, S. B. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.8.851 · Cited by 275
pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)
Swietnicki, W., Petersen, R., Gambetti, P., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27517 · Cited by 256
Cited by
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Self-citationAmyloid fibrillogenesis: themes and variations
Rochet, J.-C., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790
Hamley, I. W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700861 · Cited by 618
Prions Affect the Appearance of Other Prions
Derkatch, I. L., Bradley, M. E., Hong, J. Y., & Liebman, S. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00427-5 · Cited by 559
Aguzzi, A., & Polymenidou, M. (2004) · Cell · doi:10.1016/s0092-8674(03)01031-6 · Cited by 544
Variant Creutzfeldt-Jakob disease
Collinge, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05128-4 · Cited by 512
Self-citationLocation and properties of metal-binding sites on the human prion protein
Jackson, G. S., Murray, I., Hosszu, L. L. P., Gibbs, N., Waltho, J. P., Clarke, A. R., & Collinge, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151038498 · Cited by 497
Self-citationMonoclonal antibodies inhibit prion replication and delay the development of prion disease
White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., & Hawke, S. (2003) · Nature · doi:10.1038/nature01457 · Cited by 492
Self-citationPathway Complexity of Prion Protein Assembly into Amyloid
Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B., & Cohen, F. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111402200 · Cited by 438
Molecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 367
Self-citationTransmissible spongiform encephalopathies
Collins, S. J., Lawson, V. A., & Masters, C. L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15171-9 · Cited by 339
Moskovitz, J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.09.003 · Cited by 300
Ma, J., & Lindquist, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011578098 · Cited by 294
Styren, Hamilton, R. L., Styren, G. C., & Klunk, W. E. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800906 · Cited by 290
Conversion of PrP to a Self-Perpetuating PrP Sc -like Conformation in the Cytosol
Ma, J., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073619 · Cited by 287
Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments
Fändrich, M., Forge, V., Buder, K., Kittler, M., Dobson, C. M., & Diekmann, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303758100 · Cited by 280
A systematic review of prion therapeutics in experimental models
Trevitt, C. R. (2006) · Brain · doi:10.1093/brain/awl150 · Cited by 263
Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome
Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W. B., Menéndez-Benito, V., Dantuma, N. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.001 · Cited by 263
Self-citationBaron, G. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1031 · Cited by 261
Crystal structure of human prion protein bound to a therapeutic antibody
Antonyuk, S. V., Trevitt, C. R., Strange, R. W., Jackson, G. S., Sangar, D., Batchelor, M., Cooper, S., Fraser, C., Jones, S., Georgiou, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809170106 · Cited by 124
Self-citation
Metadata
- Authors
- Jackson, G. S., Hosszu, L. L. P., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., & Collinge, J.
- Venue
- Science
- Published
- 1999-03-19
- Volume
- 283
- Issue
- 5409
- Pages
- 1935-1937
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2021896470
- Cited by
- 364
- References
- 18
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.